file1,
file2, etc. all in the same folder or directory;
first, locate one of the files with the [Browse...] button. Then alter the
file path in the box above to include '*' character (eg. file*).
Wildcard '?' to blanket only one character works too.| Historiographs |
Grand Totals: LCS 546, GCS 8968, CR 3423 Collection span: 1938 - 2003 | |
| Word(i) List (482) Word count: 1597, All words count: 2392 | ||
| # | Word | Recs | TLCS | TGCS |
|---|---|---|---|---|
| 201 | DIMETHYL | 1 | 1 | 64 |
| 202 | ETHANOL | 1 | 1 | 64 |
| 203 | MONOMETHYLAMINO | 1 | 1 | 64 |
| 204 | SUBSTITUTED | 3 | 3 | 64 |
| 205 | INVESTIGATION | 3 | 1 | 63 |
| 206 | ISOTOPES | 2 | 2 | 63 |
| 207 | CHEMICAL | 2 | 6 | 62 |
| 208 | SYSTEMS | 3 | 6 | 62 |
| 209 | 31P | 1 | 6 | 60 |
| 210 | ACIDS | 1 | 2 | 60 |
| 211 | HYDROGEN | 1 | 2 | 59 |
| 212 | INVERSION | 1 | 2 | 59 |
| 213 | ISOLEUCYL | 1 | 1 | 59 |
| 214 | MEANS | 1 | 2 | 59 |
| 215 | NITROGEN | 1 | 2 | 59 |
| 216 | REQUIREMENTS | 1 | 1 | 59 |
| 217 | ZINC | 2 | 0 | 58 |
| 218 | ANION | 1 | 7 | 57 |
| 219 | METALLOPROTEIN | 1 | 0 | 57 |
| 220 | PHOSPHOGLUCOMUTASE | 1 | 1 | 57 |
| 221 | CATALYTIC | 1 | 3 | 56 |
| 222 | DIMENSIONAL | 1 | 3 | 56 |
| 223 | ELONGATION | 2 | 3 | 56 |
| 224 | FACTOR | 2 | 3 | 56 |
| 225 | IMPLICATIONS | 1 | 3 | 56 |
| 226 | ADP | 2 | 3 | 55 |
| 227 | PHOSPHATES | 1 | 5 | 55 |
| 228 | DIFFERENTIATION | 1 | 4 | 54 |
| 229 | FORMS | 2 | 8 | 53 |
| 230 | THIO | 2 | 8 | 52 |
| # | Word | Recs | TLCS | TGCS |
| 231 | BETAINE | 1 | 1 | 49 |
| 232 | FOLLOWED | 1 | 3 | 49 |
| 233 | PHOSPHATASE | 1 | 3 | 49 |
| 234 | BINARY | 1 | 6 | 48 |
| 235 | ESSENTIAL | 1 | 8 | 48 |
| 236 | MAGNESIUM | 1 | 8 | 48 |
| 237 | QUATERNARY | 1 | 6 | 48 |
| 238 | GAMMA | 2 | 8 | 47 |
| 239 | INTERCHANGE | 3 | 8 | 47 |
| 240 | VALYL | 3 | 8 | 47 |
| 241 | CONCENTRATION | 1 | 7 | 46 |
| 242 | METABOLISM | 2 | 0 | 46 |
| 243 | STOICHIOMETRIC | 1 | 7 | 46 |
| 244 | UNTRAINED | 2 | 0 | 46 |
| 245 | F1MET | 1 | 2 | 45 |
| 246 | APPLICATION | 2 | 1 | 44 |
| 247 | BIOCHEMISTRY | 4 | 1 | 44 |
| 248 | CHARACTERIZATION | 1 | 7 | 44 |
| 249 | DETERMINATION | 2 | 6 | 44 |
| 250 | ELITE | 1 | 0 | 44 |
| 251 | ENDOWMENT | 1 | 0 | 44 |
| 252 | ENDURANCE | 1 | 0 | 44 |
| 253 | ENERGY | 1 | 0 | 44 |
| 254 | ENVIRONMENTS | 1 | 1 | 44 |
| 255 | EVIDENCE | 1 | 0 | 44 |
| 256 | FLUORESCENT | 1 | 1 | 44 |
| 257 | GENETIC | 1 | 0 | 44 |
| 258 | LABEL | 1 | 1 | 44 |
| 259 | MEASUREMENTS | 1 | 8 | 44 |
| 260 | PYROPHOSPHORYLASE | 1 | 8 | 44 |
| # | Word | Recs | TLCS | TGCS |
| 261 | RUNNERS | 1 | 0 | 44 |
| 262 | STRUCTURES | 1 | 7 | 44 |
| 263 | SUGGESTING | 1 | 0 | 44 |
| 264 | URIDINE | 1 | 8 | 44 |
| 265 | ABDOMINAL | 1 | 0 | 43 |
| 266 | ANEURYSMS | 1 | 0 | 43 |
| 267 | AORTIC | 1 | 0 | 43 |
| 268 | ARTERY | 1 | 0 | 43 |
| 269 | ENDOLEAK | 1 | 0 | 43 |
| 270 | ENDOVASCULAR | 1 | 0 | 43 |
| 271 | INFERIOR | 1 | 0 | 43 |
| 272 | MESENTERIC | 1 | 0 | 43 |
| 273 | OCCURRENCE | 1 | 0 | 43 |
| 274 | PATENCY | 1 | 0 | 43 |
| 275 | PATIENTS | 1 | 0 | 43 |
| 276 | PREOPERATIVE | 1 | 0 | 43 |
| 277 | RAT | 3 | 0 | 43 |
| 278 | RELATIONSHIP | 1 | 0 | 43 |
| 279 | REPAIR | 1 | 0 | 43 |
| 280 | SUBSEQUENT | 1 | 0 | 43 |
| 281 | TYPE | 1 | 0 | 43 |
| 282 | ENZYMATIC | 1 | 1 | 41 |
| 283 | LABILE | 2 | 0 | 41 |
| 284 | GUANOSINE | 1 | 2 | 40 |
| 285 | INHIBITION | 2 | 3 | 40 |
| 286 | GROWTH | 1 | 3 | 39 |
| 287 | OLIGONUCLEOTIDES | 1 | 0 | 39 |
| 288 | PHOSPHOROLYSIS | 1 | 0 | 39 |
| 289 | POLYMERIZATION | 1 | 0 | 39 |
| 290 | POLYNUCLEOTIDE | 1 | 0 | 39 |
| # | Word | Recs | TLCS | TGCS |
| 291 | TUMOR | 1 | 3 | 39 |
| 292 | SINGLE | 2 | 0 | 38 |
| 293 | ANSERINE | 1 | 0 | 37 |
| 294 | DIPHOSPHOGLYCERIC | 1 | 6 | 37 |
| 295 | RELATION | 1 | 0 | 37 |
| 296 | ACCOMPANYING | 1 | 0 | 36 |
| 297 | AMINOACYLATION | 1 | 0 | 36 |
| 298 | BASE | 1 | 0 | 36 |
| 299 | CHANGE | 1 | 0 | 36 |
| 300 | DERIVATIVES | 1 | 0 | 36 |
| 301 | DINITROPHENOL | 1 | 1 | 36 |
| 302 | METF1 | 1 | 0 | 36 |
| 303 | METF3 | 1 | 0 | 36 |
| 304 | MODE | 1 | 1 | 36 |
| 305 | S4U8 | 1 | 0 | 36 |
| 306 | TERTIARY | 1 | 0 | 36 |
| 307 | UNCOUPLING | 1 | 1 | 36 |
| 308 | GLYCERATE | 2 | 10 | 34 |
| 309 | INACTIVATED | 1 | 8 | 33 |
| 310 | PURIFICATION | 1 | 2 | 33 |
| 311 | AMINO | 3 | 3 | 32 |
| 312 | FLUOROURACIL | 1 | 0 | 32 |
| 313 | FLUOROURIDINE | 2 | 3 | 32 |
| 314 | MAPPING | 1 | 2 | 31 |
| 315 | INTERACTIONS | 3 | 1 | 30 |
| 316 | RNA1VAL | 1 | 3 | 30 |
| 317 | DEDUCED | 1 | 2 | 29 |
| 318 | DEUTERIUM | 2 | 1 | 29 |
| 319 | NOVEL | 1 | 6 | 29 |
| 320 | PATHWAY | 1 | 6 | 29 |
| # | Word | Recs | TLCS | TGCS |
| 321 | STEREOSPECIFIC | 1 | 6 | 29 |
| 322 | TRANSPORT | 3 | 2 | 29 |
| 323 | CONTAINING | 2 | 3 | 27 |
| 324 | WHITE | 1 | 0 | 27 |
| 325 | 18O | 1 | 2 | 26 |
| 326 | ARSENATE | 1 | 2 | 26 |
| 327 | COMPLEXZES | 1 | 8 | 26 |
| 328 | INTERPRETATION | 1 | 8 | 26 |
| 329 | PHOSPHORYLASES | 1 | 0 | 26 |
| 330 | SOLUTIONS | 1 | 8 | 26 |
| 331 | STIMULATED | 1 | 2 | 26 |
| 332 | SURVEY | 1 | 0 | 26 |
| 333 | TRIPHOSPHATASE | 1 | 2 | 26 |
| 334 | AP5A | 1 | 3 | 24 |
| 335 | ASYMMETRIC | 1 | 3 | 24 |
| 336 | DROP | 1 | 1 | 24 |
| 337 | FALLING | 1 | 1 | 24 |
| 338 | METHOD | 1 | 1 | 24 |
| 339 | PENTAPHOSPHATE | 1 | 3 | 24 |
| 340 | ALPHA | 2 | 6 | 23 |
| 341 | DENSITY | 1 | 0 | 23 |
| 342 | DISPLACEMENT | 1 | 5 | 23 |
| 343 | OCTOCYANOMOLYBDATE | 1 | 0 | 23 |
| 344 | QUANTITATION | 1 | 5 | 23 |
| 345 | SUBSTITUTION | 1 | 5 | 23 |
| 346 | SULFUR | 1 | 5 | 23 |
| 347 | DYNAMIC | 1 | 0 | 22 |
| 348 | HORSE | 1 | 0 | 22 |
| 349 | PHOTOCHEMICALLY | 1 | 0 | 22 |
| 350 | POLARIZATION | 1 | 0 | 22 |
| # | Word | Recs | TLCS | TGCS |
| 351 | POTASSIUM | 1 | 4 | 22 |
| 352 | ADENSINE | 1 | 1 | 21 |
| 353 | ANALOGUES | 1 | 1 | 21 |
| 354 | EVALUATION | 1 | 0 | 21 |
| 355 | HEART | 1 | 0 | 21 |
| 356 | INTACT | 1 | 0 | 21 |
| 357 | ISCHEMIC | 1 | 0 | 21 |
| 358 | MYOCARDIUM | 1 | 0 | 21 |
| 359 | O18 | 1 | 1 | 21 |
| 360 | PARTIAL | 1 | 1 | 21 |
| 361 | CELLS | 4 | 0 | 20 |
| 362 | CUPRIC | 1 | 0 | 20 |
| 363 | DIPHOSPHOPYRIDINE | 1 | 0 | 20 |
| 364 | DIRECT | 1 | 5 | 20 |
| 365 | MODIFIED | 1 | 0 | 20 |
| 366 | NATIVE | 1 | 0 | 20 |
| 367 | RIBONUCLEASE | 1 | 0 | 20 |
| 368 | KETOBUTYRATE | 1 | 4 | 19 |
| 369 | MONOVALENT | 1 | 4 | 19 |
| 370 | PHOSPHOENOL | 1 | 4 | 19 |
| 371 | DISCRIMINATION | 1 | 2 | 18 |
| 372 | SYNTHETASES | 2 | 2 | 18 |
| 373 | CLOSTRIDIUM | 1 | 0 | 17 |
| 374 | DIETARY | 1 | 0 | 17 |
| 375 | ELSDENII | 1 | 0 | 17 |
| 376 | FLAVODOXIN | 1 | 0 | 17 |
| 377 | LEVEL | 1 | 0 | 17 |
| 378 | OXIDATION | 1 | 0 | 17 |
| 379 | PEPTOSTREPTOCOCCUS | 1 | 0 | 17 |
| 380 | CARCINOMA | 2 | 0 | 16 |
| # | Word | Recs | TLCS | TGCS |
| 381 | CIDNP | 2 | 1 | 16 |
| 382 | CYTOTOXICITY | 2 | 0 | 16 |
| 383 | GLIOMA | 2 | 0 | 16 |
| 384 | LIGANDS | 1 | 1 | 16 |
| 385 | NON | 2 | 1 | 16 |
| 386 | OVARIAN | 2 | 0 | 16 |
| 387 | REVERSIBLE | 2 | 2 | 16 |
| 388 | SOLUTION | 2 | 0 | 16 |
| 389 | SYNTHASE | 2 | 3 | 15 |
| 390 | ABILITY | 1 | 0 | 14 |
| 391 | AROMATIC | 1 | 1 | 14 |
| 392 | DONOR | 1 | 0 | 14 |
| 393 | EXTRINSIC | 1 | 1 | 14 |
| 394 | LASER | 1 | 1 | 14 |
| 395 | PHOTO | 1 | 1 | 14 |
| 396 | PROBE | 1 | 1 | 14 |
| 397 | PROTEINS | 1 | 1 | 14 |
| 398 | PYRIDOXAL | 1 | 1 | 14 |
| 399 | PYRIDOXYLLYSINE | 1 | 1 | 14 |
| 400 | RESIDUES | 1 | 1 | 14 |